Brighton Jones LLC Acquires Shares of 61,637 DENTSPLY SIRONA Inc. $XRAY

Brighton Jones LLC acquired a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 61,637 shares of the medical instruments supplier’s stock, valued at approximately $979,000.

A number of other large investors have also recently made changes to their positions in XRAY. AQR Capital Management LLC lifted its stake in shares of DENTSPLY SIRONA by 119.4% in the first quarter. AQR Capital Management LLC now owns 6,346,685 shares of the medical instruments supplier’s stock valued at $93,423,000 after buying an additional 3,453,662 shares in the last quarter. Goldman Sachs Group Inc. lifted its stake in shares of DENTSPLY SIRONA by 827.3% in the first quarter. Goldman Sachs Group Inc. now owns 2,434,925 shares of the medical instruments supplier’s stock valued at $36,378,000 after buying an additional 2,172,343 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its stake in shares of DENTSPLY SIRONA by 11.3% in the first quarter. Price T Rowe Associates Inc. MD now owns 13,961,759 shares of the medical instruments supplier’s stock valued at $208,590,000 after buying an additional 1,412,517 shares in the last quarter. Ninety One UK Ltd bought a new position in shares of DENTSPLY SIRONA in the second quarter valued at $18,418,000. Finally, Edmond DE Rothschild Holding S.A. lifted its stake in shares of DENTSPLY SIRONA by 26.4% in the first quarter. Edmond DE Rothschild Holding S.A. now owns 2,913,400 shares of the medical instruments supplier’s stock valued at $43,526,000 after buying an additional 609,300 shares in the last quarter. 95.70% of the stock is owned by institutional investors.

DENTSPLY SIRONA Stock Performance

NASDAQ XRAY opened at $13.09 on Tuesday. DENTSPLY SIRONA Inc. has a 52-week low of $11.69 and a 52-week high of $24.86. The company has a 50-day simple moving average of $13.33 and a 200 day simple moving average of $14.51. The company has a debt-to-equity ratio of 1.13, a quick ratio of 1.11 and a current ratio of 1.69. The company has a market capitalization of $2.61 billion, a PE ratio of -2.76, a price-to-earnings-growth ratio of 0.82 and a beta of 0.96.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.50 by $0.02. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The business had revenue of $936.00 million during the quarter, compared to the consensus estimate of $929.67 million. During the same quarter last year, the company posted $0.49 earnings per share. The firm’s quarterly revenue was down 4.9% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. On average, research analysts predict that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 10th. Investors of record on Friday, September 26th were issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 4.9%. The ex-dividend date was Friday, September 26th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -13.50%.

Analyst Ratings Changes

A number of research firms have weighed in on XRAY. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research note on Wednesday, October 8th. Needham & Company LLC reiterated a “hold” rating on shares of DENTSPLY SIRONA in a report on Friday, September 26th. UBS Group lowered their target price on shares of DENTSPLY SIRONA from $25.00 to $24.00 and set a “buy” rating for the company in a report on Friday, August 8th. Stifel Nicolaus lowered their target price on shares of DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating for the company in a report on Friday, August 8th. Finally, Wells Fargo & Company lowered their target price on shares of DENTSPLY SIRONA from $16.00 to $15.00 and set an “equal weight” rating for the company in a report on Friday, August 8th. Two investment analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, DENTSPLY SIRONA currently has an average rating of “Hold” and an average price target of $18.00.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.